February 20, 2025

Youth Pulmonary Embolism Trends Identified

A large-scale cohort study reveals that early detection, accurate diagnostics, and personalized treatment plans significantly improve survival rates in pulmonary embolism patients by addressing key risk factors and optimizing therapeutic strategies.

Conexiant

February 20, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 20, 2025

NY Sues Major Vape Distributors Over Youth Marketing

Attorney General Letitia James files lawsuit against 13 e-cigarette companies for allegedly targeting minors with flavored nicotine products, seeking hundreds of millions in damages and penalties.

Conexiant

February 19, 2025

Hospital Occupancy to Reach 85% by 2035

The projection is driven by a decline in staffed beds and an aging population.

Conexiant

February 18, 2025

FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing

FDA grants 510(k) clearance for Hologic’s Aptima SARS-CoV-2 assay, which uses the Panther system for high-throughput RNA detection.

Conexiant

February 11, 2025

Rare Pulmonary Lesions in CNO Show Favorable Outcomes

Pulmonary lesions in chronic nonbacterial osteomyelitis are rare and often asymptomatic, with most resolving over time, researchers report.

Conexiant

February 10, 2025

Guideline-Based Mental Health Treatment Gaps Identified

Researchers found significant gaps in mental health and substance use disorder treatment.

Conexiant

February 05, 2025

FDA Approves Tocilizumab Biosimilar

FDA approves AVTOZMA after phase III trial confirms equivalence in efficacy, safety, and pharmacokinetics for RA and other inflammatory conditions.

Conexiant

February 03, 2025

Vascular Access Strategies for Cardiac Arrest

No significant difference in survival or neurologic outcomes between intraosseous and intravenous vascular access in out-of-hospital cardiac arrest was found.

Conexiant